A phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine (Gem) (GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract ...
Variant tumor histology in patients with transitional cell carcinoma (TCC) is an indication for neoadjuvant chemotherapy, according to researchers. Wassim Kassouf, MD, and his colleagues at the M.D.
Labtests Auckland Ltd has purchased Diagnostic MedLab’s (DML) clinical pathology and collection service operations. Dr Margaret Wilsher, Auckland DHB’s Chief Medical Officer made this announcement ...
Gemcitabine/cisplatin in patients with advanced bladder and impaired renal function: A retrospective analysis. Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback